| Greg Dale Schapansky, RPH | |
|
2820 Independence Dr, Livermore, CA 94551-7628 | |
| (925) 456-7209 | |
| (925) 243-1276 |
| Full Name | Greg Dale Schapansky |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2820 Independence Dr, Livermore, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255778965 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH30970 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Greg Dale Schapansky, RPH 2820 Independence Dr, Livermore, CA 94551-7628 Ph: (925) 456-7209 | Greg Dale Schapansky, RPH 2820 Independence Dr, Livermore, CA 94551-7628 Ph: (925) 456-7209 |
News Archive
For the first time, researchers have access to detailed information about how an urban Aboriginal population in Canada uses health care. A new study, called Our Health Counts, uses this health database to clearly demonstrate the unique challenges faced by urban Aboriginal people in Canada - according to researchers at St. Michael's Hospital.
Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.
As more indoor venues require proof of vaccination for entrance and with winter — as well as omicron, a new covid variant — looming, scientists and public health officials are debating when it will be time to change the definition of "fully vaccinated" to include a booster shot.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group, announced that the 6-month sustained-release formulation of Decapeptyl®1 (triptorelin embonate2 22.5 mg) successfully completed its European decentralised registration procedure involving nine countries: Germany (reference member state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands.
Rice University scientists have found that mutations of small effect can turn out to be game changers in the bacterial fight against antibiotic drugs.
› Verified 6 days ago
Mike Ainsley Ring Jr., PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4300 Las Positas Rd, Livermore, CA 94551 Phone: 925-245-1406 Fax: 925-245-1406 | |
Anne-marie Vo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pullman St Bldg G, Livermore, CA 94551 Phone: 888-218-6245 | |
Brian Bui, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pullman St Bldg G, Livermore, CA 94551 Phone: 925-960-6996 | |
Miss May Chung, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pullman St, Livermore, CA 94551 Phone: 925-453-3953 | |
Evelyn Chun, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Las Positas Rd, Livermore, CA 94551 Phone: 925-243-4995 | |
Dr. Nick T Truong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 968 Murrieta Blvd, Livermore, CA 94550 Phone: 925-373-0455 | |
Tiffany Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pullman St, Livermore, CA 94551 Phone: 925-453-3966 |